Abstract:<p>Hair greying (canities) is one of the earliest, most visible ageing‐associated phenomena, whose modulation by genetic, psychoemotional, oxidative, senescence‐associated, metabolic and nutritional factors has long attracted skin biologists, dermatologists, and industry. Greying is of profound psychological and commercial relevance in increasingly ageing populations. In addition, the onset and perpetuation of defective melanin production in the human anagen hair follicle pigmentary unit (HFPU) provides a superb model for interrogating the molecular mechanisms of ageing in a complex human mini‐organ, and greying‐associated defects in bulge melanocyte stem cells (MSCs) represent an intriguing system of neural crest‐derived stem cell senescence. Here, we emphasize that human greying invariably begins with the gradual decline in melanogenesis, including reduced tyrosinase activity, defective melanosome transfer and apoptosis of HFPU melanocytes, and is thus a primary event of the anagen hair bulb, not the bulge. Eventually, the bulge MSC pool becomes depleted as well, at which stage greying becomes largely irreversible. There is still no universally accepted model of human hair greying, and the extent of genetic contributions to greying remains unclear. However, oxidative damage likely is a crucial driver of greying <i>via</i> its disruption of HFPU melanocyte survival, MSC maintenance, and of the enzymatic apparatus of melanogenesis itself. While neuroendocrine factors [e.g. alpha melanocyte‐stimulating hormone (α‐MSH), adrenocorticotropic hormone (ACTH), ß‐endorphin, corticotropin‐releasing hormone (CRH), thyrotropin‐releasing hormone (TRH)], and micropthalmia‐associated transcription factor (MITF) are well‐known regulators of human hair follicle melanocytes and melanogenesis, how exactly these and other factors [e.g. thyroid hormones, hepatocyte growth factor (HGF), P‐cadherin, peripheral clock activity] modulate greying requires more detailed study. Other important open questions include how HFPU melanocytes age intrinsically, how psychoemotional stress impacts this process, and how current insights into the gerontobiology of the human HFPU can best be translated into retardation or reversal of greying.</p>

Risk Factors Associated with Premature Hair Greying of Young Adult

Risk Factors for Premature Hair Graying in Young Turkish Adults

Association of premature hair graying with family history, smoking, and obesity: a cross-sectional study

Association Between Premature Hair Greying and Metabolic Risk Factors: A Cross-sectional Study

Association of epidemiological and biochemical factors with premature graying of hair: A case–control study

Premature Graying of Hair: A Comprehensive Review and Recent Insights

Therapeutics of premature hair graying: A long journey ahead

Hair Graying Regulators Beyond Hair Follicle

Prevalence and Predictors of Premature Graying of Hair Before the Age of 30: A Cross‐Sectional Study in Saudi Arabia

The biology of human hair greying

Premature graying of hair: Risk factors, co-morbid conditions, pharmacotherapy and reversal-A systematic review and meta-analysis

Greying of the human hair: a worldwide survey, revisiting the '50' rule of thumb

Premature graying of hair is a risk marker for osteopenia

Global Downregulation of Pigmentation-Associated Genes in Human Premature Hair Graying

The Pattern of Hair Dyeing in Koreans with Gray Hair

Serum Iron, Zinc, and Copper Concentration in Premature Graying of Hair

Reversal of premature hair graying treated with a topical formulation containing α-melanocyte-stimulating hormone agonist (Greyverse Solution 2%)

The possibilities of correction of premature greying of hair and involutive hair changes

Sleep Pattern Factors on Premature Skin Aging in YARSI University Medical Students, Force of 2021

Premature Graying As A Consequence of Compromised Antioxidant Activity in Hair Bulb Melanocytes and Their Precursors